Summary
The primary metabolite of cyclophosphamide (CP, 1), i.e. 4-hydroxy-CP 2, has high pharmacological activity, but it is a very unstable compound. Chemical approaches to the stabilization involved in the substitution of the hydroxy group at the C 4-position, especially by a sulfoalkylthio-moiety. Within this new class of compounds ASTA Z 7557 (2-(bis-(2-chloroethyl))-amino-cis-4-((2-sulfoethyl)-thio)-tetrahydro-2H-1,3,2-oxazaphosphorine-r-2-oxide cyclohexylamine salt, i.e. cis-4-sulfoethylthio-CP, cis-13) was chosen for further evaluation. Cis-13 was synthesized by condensation of compound 2 and 2-mercapto-ethanesulfonic acid cyclohexylamine salt 14 in aqueous acetone yielding the cis-isomer with high stereoselectivity. It is a white crystalline powder, m.p. 126–134°C, stable at room temperature, with a solubility of 16% in water. The stereochemistry was confirmed by NMR-data and X-ray diffraction. In 0.07 M phosphate buffer at pH 7 and 37°C cis-13 isomerizes to the epimer trans-13, equilibrating at a cis-trans-ratio of 59 to 41 within less than 5 minutes. Simultaneously a rapid initial hydrolysis occurs to 2 and 14 followed by a time period with lower degradation due to the decomposition of 2. The rate of release of 2 increases with decreasing concentration and especially by addition of an oxidant. It could be retarded by addition of the corresponding thiol mesna, sodium 2-mercapto-ethanesulfonate 15, or of another thiol. In the presence of 3-mercapto-propane sulfonate 13 yielded 4-(3-sulfopropyl)thio-CP17.
With changing pH values from 2 to 9, the lowest hydrolytic speed was observed at pH 4.0 to 4.3. For clinical use cis-13 is prepared as a lyophilisate containing additional sodium citrate buffer to guarantee this optimal pH value.
Similar content being viewed by others
References
Brock N: Oxazaphosphorine cytostatics: structure-activity relationships, selectivity and metabolism, regional detoxification. In DN Reinhoudt, TA Connors, HM Pinedo and KW van de Poll (eds): Structure-activity relationships of anti-tumor agents. Martinus Nijhoff Publishers, The Hague, Boston, London, 1983, pp 239–267
Colvin M, Brundrett RB, Kan M-NN, Jardine I, Fenselau C: Alkylating properties of phosphoramide mustard. Cancer Res 36:1121–1126, 1976
Takamizawa A, Matsumoto S, Iwata T, Kentagiri K, Tochino Y, Yamaguchi K: Studies on cyclophosphamide metabolites and their related compounds II. Preparation of an active species of cyclophosphamide and some related compounds. J Amer Chem Soc 95:985–986, 1973
Peter G, Wagner T, Hohorst H-J: Studies on 4-hydro-peroxy-cyclophosphamide (NSG-181815): A simple preparation method and its application for the synthesis of a new class of “activated” sulfur-containing cyclophosphamide (NSC-26271) derivatives. Cancer Treat Rep 60:429–435, 1976
Hirano T, Klesse W, Heusinger GH, Lambert G, Ringsdorf H: Synthesis of activated cyclophosphamide derivatives. Tetrahedron Lett: 883–886, 1979
Scheffler G, Niemeyer U, Brock N, Pohl J: Oxazaphos-phorin-4-thio-alkansulfonsäuren und deren neutrale Salze, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. Ger Offen 31 11 428, Asta Werke AG, Anm 24.3.1981
Brock N, Stekar J, Pohl J, Niemeyer U, Scheffler G: Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. Arzneim-Forsch/Drug Res 29:659–661, 1979
Low FJ, Borch RF, Sladek NE: Conversion of 4-hydro-peroxy-cyclophosphamide and 4-hydroxy-cyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysts. Cancer Res 42:830–837, 1982
Draeger U, Peter G, Hohorst H-J: Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds. Cancer Treat Rep 60:355–359, 1976
Peter G, Hohorst H-J: Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides. Cancer Chemother Pharmacol 3:181–188, 1979
Hirano T, Ringsdorf H, Zaharko DS: Antitumor activity of monomeric and polymeric cyclophosphamide derivatives compared with in vitro hydrolysis. Cancer Res 40:2263–2267, 1980
Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77, 1959
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niemeyer, U., Engel, J., Scheffler, G. et al. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide. Invest New Drugs 2, 133–139 (1984). https://doi.org/10.1007/BF00232342
Issue Date:
DOI: https://doi.org/10.1007/BF00232342